28 December 2007
Colchicine against ischemia-reperfusion injury in experimental lung transplantation
Jaroslaw Pieróg, Bartosz Kubisa, Tomasz Grodzki, Janusz Wójcik, Juliusz Pankowski, Justyna Ostrowska, Zygmunt Juzyszyn, Marek DroździkAnn Transplant 2007; 12(4): 32-37 :: ID: 764932
Abstract
Background: To asses the influence of colchicine, a potent antinflammatory agent and neutrophile migration inhibitor, on Ischemia-Reperfusion Injury (IRI) in rat lung isogeneic transplantation.
Material/Methods: Isogeneic, orthotropic single left lung transplantations were performed among male Wistar rats after total ischemic graft storage time of 12 or 18 hours in temperature of 4°C. Recipients received either no specific treatment (control) or Colchicine 1.2 mg/kg/d ip. Twenty-four hours after transplantation, the native contralateral lung was occluded to assess graft gas exchange function (PaO[sub]2[/sub]). The lung graft was excised and assessed for Wet/Dry ratio (W/D) as a measure of edema, Myeloperoxidase activity (MPO) as a measure of neutrophile migration and histology.
Results: PaO[sub]2[/sub] differences were not significant among all groups. Comparing colchicine to control group, the W/D ratio 3.93±0.66 vs. 1.86±0.32, p=0.002 and MPO 8.1±3.34 vs. 5.87±1.76, p=0.046 were significantly higher for 18 hours colchicine group.
Comparing 18 to 12 hours time groups, the W/D ratio 5.70±1.53 vs. 1.86±0.32, p=0.007 for control groups and 5.40±1.49 vs. 3.93±0.66, p=0.049 for colchicine groups were signifi cantly higher for both 12 h groups. Histology favored colchicine treated animals.
Conclusions: Colchicine in tested dose does not decrease edema after lung transplantation and does not improve lung function. 18 vs. 12 hours total ischemic graft storage time causes less lung edema.
Keywords: Colchicine, Ischemia reperfusion injury, Lung Transplantation
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860